Detalles de la búsqueda
1.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial.
Lancet
; 389(10066): 255-265, 2017 01 21.
Artículo
en Inglés
| MEDLINE | ID: mdl-27979383
2.
Atezolizumab versus docetaxel for patients with previously treated non-small-cell lung cancer (POPLAR): a multicentre, open-label, phase 2 randomised controlled trial.
Lancet
; 387(10030): 1837-46, 2016 Apr 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-26970723
3.
Bevacizumab plus capecitabine versus capecitabine alone in elderly patients with previously untreated metastatic colorectal cancer (AVEX): an open-label, randomised phase 3 trial.
Lancet Oncol
; 14(11): 1077-1085, 2013 Oct.
Artículo
en Inglés
| MEDLINE | ID: mdl-24028813
4.
CEA-CD3 bispecific antibody cibisatamab with or without atezolizumab in patients with CEA-positive solid tumours: results of two multi-institutional Phase 1 trials.
Nat Commun
; 15(1): 4091, 2024 May 15.
Artículo
en Inglés
| MEDLINE | ID: mdl-38750034
5.
Efficacy and safety of bevacizumab in metastatic colorectal cancer: pooled analysis from seven randomized controlled trials.
Oncologist
; 18(9): 1004-12, 2013.
Artículo
en Inglés
| MEDLINE | ID: mdl-23881988
6.
Long-term survival follow-up of atezolizumab in combination with platinum-based doublet chemotherapy in patients with advanced non-small-cell lung cancer.
Eur J Cancer
; 101: 114-122, 2018 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-30053670
7.
Real-world treatment patterns for patients receiving second-line and third-line treatment for advanced non-small cell lung cancer: A systematic review of recently published studies.
PLoS One
; 12(4): e0175679, 2017.
Artículo
en Inglés
| MEDLINE | ID: mdl-28410405
8.
Atezolizumab in combination with bevacizumab enhances antigen-specific T-cell migration in metastatic renal cell carcinoma.
Nat Commun
; 7: 12624, 2016 08 30.
Artículo
en Inglés
| MEDLINE | ID: mdl-27571927
9.
Atezolizumab versus docetaxel in patients with previously treated non-small-cell lung cancer (OAK): a phase 3, open-label, multicentre randomised controlled trial
Lancet
; 389: 255-265, enero, 2017.
Artículo
en Inglés
| URUCAN | ID: bcc-5147
10.
Isolation of targeted AAV2 vectors from novel virus display libraries.
J Gene Med
; 8(11): 1307-19, 2006 Nov.
Artículo
en Inglés
| MEDLINE | ID: mdl-16955542
Resultados
1 -
10
de 10
1
Próxima >
>>